Cargando…
Navigating a Path to Rifampicin Resistance in Tuberculosis
For model bacteria, genetic drug resistance usually arises from antibiotic-tolerant subpopulations, but whether this is true for the globally important pathogen Mycobacterium tuberculosis—the cause of tuberculosis—is not known. Here, we discuss a recent article by Sebastian et al. (J. Sebastian, A....
Autores principales: | Agarwal, Sakshi, Javid, Babak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973358/ https://www.ncbi.nlm.nih.gov/pubmed/36688640 http://dx.doi.org/10.1128/mbio.02952-22 |
Ejemplares similares
-
Commentary: Navigating the path rarely taken
por: Lazar, John F.
Publicado: (2020) -
Navigating the Path to Publication: A Guide for the Novice Researcher
por: Fawcett, Mason A., et al.
Publicado: (2023) -
Navigating the unchartable: paths to promotion and tenure in health professions education
por: Bates, Joanna, et al.
Publicado: (2016) -
Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis
por: Zhang, Zehua, et al.
Publicado: (2014) -
Clinically relevant mutations in mycobacterial LepA cause rifampicin-specific phenotypic resistance
por: Wang, Bi-Wei, et al.
Publicado: (2020)